Wuhan Deferred Long Term Liab from 2010 to 2024
| 300871 Stock | 11.40 0.01 0.09% |
Deferred Long Term Liabilities | First Reported 2010-12-31 | Previous Quarter 334.5 K | Current Value 487.7 K | Quarterly Volatility 222.9 K |
Check Wuhan Hvsen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Wuhan Hvsen's main balance sheet or income statement drivers, such as Interest Expense of 29.6 M, Other Operating Expenses of 5.6 M or Net Income Applicable To Common Shares of 96.4 M, as well as many indicators such as . Wuhan financial statements analysis is a perfect complement when working with Wuhan Hvsen Valuation or Volatility modules.
Wuhan | Deferred Long Term Liab |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Wuhan Stock
Wuhan Hvsen financial ratios help investors to determine whether Wuhan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Wuhan with respect to the benefits of owning Wuhan Hvsen security.